Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease.
Erythropoietin is a growth factor commonly used to manage anemia in patients with chronic kidney disease.A significant clinical challenge is relative resistance to erythropoietin, which leads to use of successively Tinted Sunscreen higher erythropoietin doses, failure to achieve target hemoglobin levels, and increased risk of adverse outcomes.Eryth